Web-based telemedicine system is useful for monitoring glucose control in pregnant women with diabetes.

Source: Carral, F., et al. (2015). - Pubmed ID: 25629547

Setting: Spain, University hospital

Study design:

CT –pro

Follow up: NA

Patient group:

Sample size:

Total: 104 (93)

IG: 40 (38)

CG: 64 (55)

Inclusion criteria:

Age over 18 years

Diabetes before or during pregnancy

Type of technology:

Web-site (‘diabetic’)
– data transfer
– monitoring
– messaging

Email or phone
– feedback on data

Intervention:

Intervention:

Glucose control was evaluated every 2 weeks on a Web-based telemedicine system called ‘‘DiabeTIC’’ with feedback by email or phone message. Furthermore in clinic evaluation at the diabetes unit every 6–8 weeks. All patients were reevaluated in a face-to-face visit between 6 to 12

weeks after delivery.

Duration: NA

Add on: –

Control group: Glucose was evaluated every 2 or 3 weeks until delivery at a diabetes unit.

Clinical effect/ Patient safety:

Clinical effect:

HbA1c →

Insulin therapy ↓

Cesarean delivery →

 

Patient safety:

NA

Patient experiences/ Staff experiences:

Patient experiences:

NA

Staff experiences:

NA

Costs and organization:

Investment:

Material

– Bloodglucose monitor

Staff resources

– Development of website

Running:

Staff resources

monitoring patients

– messaging patients

Organization:

NA

Health care utilization:

Diabetes unit visits ↓

Nurse educator visits ↓

GP visits ↓

Scroll to Top

Information

“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)